Announcement • Mar 17
Bioten Co., Ltd., Annual General Meeting, Mar 31, 2026 Bioten Co., Ltd., Annual General Meeting, Mar 31, 2026, at 09:01 Tokyo Standard Time. Location: conference room, 201, cheomdangwahak-ro, jeonbuk-do, jeongeup South Korea Announcement • Mar 14
Bioten Co., Ltd., Annual General Meeting, Mar 26, 2025 Bioten Co., Ltd., Annual General Meeting, Mar 26, 2025, at 09:01 Tokyo Standard Time. Location: conference room, 107, 3sandan 4-gil, buk-myeon, jeonbuk-do, jeongeup South Korea New Risk • Feb 14
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: ₩14.2b (US$9.85m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Share price has been highly volatile over the past 3 months (22% average weekly change). Market cap is less than US$10m (₩14.2b market cap, or US$9.85m).